查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生育药物全球市场规模、份额、行业趋势分析报告：按最终用户、分销渠道（医院药房、专业/零售药房、在线药房）、药物类别、地区、展望和预测，2022-2028 年版
市场调查报告书
商品编码
1184301

生育药物全球市场规模、份额、行业趋势分析报告：按最终用户、分销渠道（医院药房、专业/零售药房、在线药房）、药物类别、地区、展望和预测，2022-2028 年版

Global Infertility Drugs Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel (Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy), By Drug Class, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 217 Pages | 订单完成后即时交付

价格

到 2028 年，全球生育药物市场规模预计将达到 48 亿美元，预测期内復合年增长率为 6.2%。

例如，Oxolife 等大公司目前正在研发一流的候选产品 OXO-001。 该产品增强与子宫内膜的结合，以优化胚胎植入过程。 它满足了全世界接受辅助生殖技术的女性的医疗需求，因为没有其他方法可以改善子宫内膜植入环境。

市场发展可能会受到药物替代品的可用性和采用率上升的不利影响。 发表在《生殖生物医学》杂誌上的一项研究报告称，到 2021 年 11 月，全球每年将进行超过 250 万例体外受精病例。 在大多数欧洲国家，试管婴儿治疗的费用通常是全额支付的。 因此，预计在整个预测期内更换的风险都很高。

COVID-19 影响分析

市场受到 COVID-19 大流行的负面影响。 生育药物市场受到 COVID-19 供应链中断和生育药物製造所需关键商品交付延迟的负面影响。 此外，在 COVID-19 期间全球暂停或推迟生殖医学也阻碍了市场扩张。 从 2020 年 4 月到 2022 年 3 月，48 个州的 228 家医院的生育治疗下降了 83%。 美国生殖医学学会 (ASRM) 于 2020 年 3 月发布指令，暂停包括不孕症在内的所有诊断和治疗服务。

市场增长因素

增加男性和女性不育的因素

推动生育药物市场发展的是世界各地不孕症和难产率的增加。 男性和女性的不育症是由多种情况引起的，包括糖尿病、子宫蓄脓、睪丸疾病、荷尔蒙失调、更年期、尿路感染、盆腔炎 (PID)、子宫内膜异位症和卵巢囊肿。这是因为有一个可能性 吸烟、合成代谢类固醇的使用、压力和肥胖等生活方式的改变是增加生育药物需求的因素。

增加研发以获得更好的治疗

随着对诱导怀孕和分娩的有效治疗方法的研究和开发不断进行，生育药物市场预计将显着扩大。 例如，2014 年，美国国立卫生研究院 (NIH) Eunice Kennedy Shriver 国家儿童健康与人类发展研究所 (NICHD) 的一组研究人员发现，接受来曲唑治疗的女性接受标准药物克罗米芬治疗。已发现排卵率和出生率高于

市场製约因素

可能的副作用

无论女性选择宫腔内人工授精 (IUI)、体外受精 (IVF) 还是任何其他类型的治疗，生育药物都是治疗过程中非常重要的因素。 这些药物用于刺激某些激素的产生并平衡体内其他物质的水平。 给予促性腺激素以促进雌性卵子成熟后的释放。 多胎妊娠，如双胞胎或三胞胎、卵巢过度刺激综合征 (OHSS) 和异位妊娠（卵子着床在输卵管而不是子宫）都是可能的副作用。有可能

最终用户视角

生育药物市场按最终用户分为男性和女性。 2021 年，女性细分市场以最大的收入份额引领市场。 这种优势可能与女性生育药物的广泛使用有关。 根据美国卫生与公共服务部的数据，美国有 11% 的育龄妇女和 9% 的男性不育。

销售渠道前景

生育药物市场按销售渠道细分为医院药店、专业和零售药店以及在线药店。 2021 年，在线药店在市场上产生了可观的收入份额。 在线临床连锁店的出现，为患者提供预定的药物递送，并由于与不孕症相关的社会耻辱而促进患者的自由裁量权，可能促成了这一细分市场的兴起。

药物类别展望

生育药物市场按药物类别分为促性腺激素、芳香□抑製剂、选择性雌激素受体调节剂 (SERM)、多巴胺激动剂等。 促性腺激素部分将在 2021 年占据市场最高收入份额。 这被认为是由于它是一种昂贵的产品，并且由于其高功效而具有增加消费的效果。 促性腺激素 Gonal-F、Follitism、Menopur 和 Bravelle 是最常用于治疗患者生育能力的药物。

区域展望

按地区划分，生育药物市场分为北美、欧洲、亚太地区和 LAMEA。 由于几种生育药物的推出和迅速采用，北美在 2021 年以最高收入份额主导生育药物市场。 该地区不孕不育研究活动的增加有望提供更多的就业机会。 例如，Ferring B.V.和 Igenomix 于 2020 年 6 月签订了一项为期四年的研究协议，合作开发创新的治疗解决方案，以治疗妊娠相关疾病患者。

内容

第一章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场规模
  • 细分
    • 全球生育药物市场，按最终用户分类
    • 全球生育药物市场，按分销渠道
    • 全球生育药物市场，按药物类别
    • 全球生育药物市场，按地区
  • 调查方法

第 2 章市场概述

  • 介绍
    • 概览
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动力
    • 市场製约因素

第 3 章全球生育药物市场：按最终用户分类

  • 女装全球市场：按地区
  • 全球男装市场：按地区

第 4 章全球生育药物市场：按分销渠道

  • 全球医院药房市场，按地区
  • 专卖店和零售药店的全球市场，按地区
  • 全球在线药店市场：按地区

第 5 章全球生育药物市场：按药物类别分类

  • 全球促性腺激素市场：按地区
  • 全球芳香□抑製剂市场，按区域划分
  • 按地区划分的全球选择性雌激素受体调节剂 (SERM) 市场
  • 多巴胺激动剂的全球市场：按地区
  • 世界其他地区的世界市场

第 6 章全球生育药物市场：区域市场

  • 北美
    • 按国家/地区划分的北美生育药物市场
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 按国家/地区划分的欧洲生育药物市场列表
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲
  • 亚太地区
    • 亚太生育药物市场：按国家/地区分类
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • 拉美
    • LAMEA 生育药物市场：按国家/地区分类
      • 巴西
      • 阿根廷
      • 阿联酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 其他拉美地区

第七章公司简介

  • Abbott Laboratories
  • Bayer AG
  • Novartis AG
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A
  • Ferring Holdings SA
  • Organon & Co
  • Mankind Pharma Ltd.

The Global Infertility Drugs Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.2 % CAGR during the forecast period.

Medicines used to cure infertility and improve a person's reproductive health are referred to as infertility drugs. They may be ingested or administered intravenously. Gonadotrophins, aromatase inhibitors, selective oestrogen receptor modulators (SERMs), biguanides, dopamine agonists, ovulatory stimulants, and tricyclic antidepressants are a few of the regularly prescribed infertility medications.

Women function by promoting ovulation and ovarian follicle formation, while males support the recovery of testosterone levels and enhance the quality of sperm to promote conception. Infertility medications have been more popular among couples who are not able to conceive current history. The market participants are working to introduce cutting-edge medications for the treatment of infertility.

For example, major firms like Oxolife are now working on the development of the first-in-class product candidate, OXO-001, which enhances the binding to the uterine endometrium's inner lining in order to optimize the embryo implantation process. The creation of such items fills a medical necessity that affects women throughout the globe who undertake assisted reproduction because there is no replacement to enhance the endometrium's circumstances for embryo implantation.

The development of the market may be adversely affected by the availability of potent substitutes for drugs and the rising rate of their adoption. Over 2.5 million IVF operations would reportedly be carried out yearly globally in November 2021, according to a study that was published in the journal Reproductive Biomedicine. Many IVF treatments are fully funded in the majority of European nations. As a result, throughout the projection period, the danger of replacements is anticipated to be significant.

COVID-19 Impact Analysis

The market was negatively affected by the COVID-19 pandemic. The market for infertility medications was negatively impacted by the supply chain disruption caused by COVID-19 and the delay in the delivery of crucial goods needed for infertility drug manufacturing. Additionally, the global stoppage or postponement of reproductive treatments during COVID-19 hampered the market's expansion. During April 2020 and March 2022, the number of patients seeking infertility treatments at 228 hospitals across 48 states decreased by 83%. The American Society for Reproductive Medicines (ASRM) issued a directive to stop all diagnostic and therapeutic operations, including infertility, in March 2020.

Market Growth Factor

Factors Increasing Infertility Cases in Men and Women

The growing prevalence of infertility or the difficulty of bringing a baby to term throughout the world is what fuels the market for infertility medications. Infertility may be brought on by a number of illnesses that affect both men and women, including diabetes, cystic fibrosis, testicular failure, hormonal imbalances, menopausal disorders, urinary tract infections, pelvic inflammatory disease (PID), endometriosis, ovarian cysts, among others. Smoking, using anabolic steroids, stress, obesity, and other poor lifestyle choices are to blame for the rise in instances of these problems, which also contributes to the need for infertility medications.

Increasing Research and Development for Better Treatment

Due to growing research and development studies for more efficient treatments to induce conception and deliver live babies, the market for infertility medications is anticipated to expand significantly. For example, a group of researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) discovered in 2014 that women treated with letrozole have higher rates of ovulation and live births than women treated with the standard medication, Clomiphene.

Market Restraining Factor

Possibility of any adverse effects

Whether women choose to have intrauterine insemination (IUI), in vitro fertilization (IVF), or other types of treatments, fertility medications are a critical component of the treatment process. These drugs are used to encourage the body to produce certain hormones and to balance the levels of other substances. Gonadotropins are administered to encourage a woman's eggs to release once they are mature. The possibility of multiple births, including twins and triplets, ovarian hyperstimulation syndrome (OHSS), and ectopic pregnancy (eggs implanting on the fallopian tubes rather than in the uterus), are all possible adverse effects of this (enlargement of the ovaries).

End User Outlook

Based on end-user, the infertility drugs Market is divided into Men and Women. The women segment led the market with the largest revenue share in the market during 2021. This dominance may be related to the widespread accessibility of female infertility medications. In the United States, 11% of women and 9% of males of reproductive age have infertility, according to the U.S. Department of Health and Human Services.

Distribution Channel Outlook

Based on distribution channel, the Infertility Drugs Market is divided into Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy. Online Pharmacy generated the significant revenue share during 2021 in the market. The emergence of online clinical chains, which provide patients with scheduled medication deliveries and promote patient discretion owing to the social stigma connected with the ailment, might be credited with the segment's rise.

Drug Class Outlook

Based on drug class, the infertility drugs market is classified into Gonadotropins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Dopamine Agonists, and Others. The gonadotropins segment accounted for the highest revenue share in the market in 2021. This may be ascribed to the expensive nature of the goods and the greater efficacy's effect on increasing consumption. The gonadotropins Gonal-F, Follitism, Menopur, and Bravelle, are some of the most often prescribed for treating infertility in patients.

Regional Outlook

Based on region, the Infertility Drugs Market is divided into North America, Europe, Asia Pacific, and LAMEA. North America dominated the Infertility Drugs Market in 2021 with the highest revenue share due to the introduction and quick adoption of several infertility medications. It is anticipated that rising infertility research activity in the area would provide additional job possibilities. For instance, Ferring B.V. and Igenomix signed a four-year research agreement in June 2020 to collaborate on the development of innovative therapeutic solutions for the care of patients with disorders associated with pregnancy.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, Novartis AG, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sanofi S.A., Ferring Holdings SA, Organon & Co. and Mankind Pharma Ltd.

Scope of the Study

Market Segments covered in the Report:

By End User

  • Women
  • Men

By Distribution Channel

  • Hospital Pharmacy
  • Specialty & Retail Pharmacy
  • Online Pharmacy

By Drug Class

  • Gonadotropins
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Dopamine Agonists
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Bayer AG
  • Novartis AG
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Sanofi S.A.
  • Ferring Holdings SA
  • Organon & Co.
  • Mankind Pharma Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Infertility Drugs Market, by End User
    • 1.4.2 Global Infertility Drugs Market, by Distribution Channel
    • 1.4.3 Global Infertility Drugs Market, by Drug Class
    • 1.4.4 Global Infertility Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Infertility Drugs Market by End-user

  • 3.1 Global Women Market by Region
  • 3.2 Global Men Market by Region

Chapter 4. Global Infertility Drugs Market by Distribution Channel

  • 4.1 Global Hospital Pharmacy Market by Region
  • 4.2 Global Specialty & Retail Pharmacy Market by Region
  • 4.3 Global Online Pharmacy Market by Region

Chapter 5. Global Infertility Drugs Market by Drug Class

  • 5.1 Global Gonadotropins Market by Region
  • 5.2 Global Aromatase Inhibitors Market by Region
  • 5.3 Global Selective Estrogen Receptor Modulators (SERMs) Market by Region
  • 5.4 Global Dopamine Agonists Market by Region
  • 5.5 Global Others Market by Region

Chapter 6. Global Infertility Drugs Market by Region

  • 6.1 North America Infertility Drugs Market
    • 6.1.1 North America Infertility Drugs Market by End-user
      • 6.1.1.1 North America Women Market by Country
      • 6.1.1.2 North America Men Market by Country
    • 6.1.2 North America Infertility Drugs Market by Distribution Channel
      • 6.1.2.1 North America Hospital Pharmacy Market by Country
      • 6.1.2.2 North America Specialty & Retail Pharmacy Market by Country
      • 6.1.2.3 North America Online Pharmacy Market by Country
    • 6.1.3 North America Infertility Drugs Market by Drug Class
      • 6.1.3.1 North America Gonadotropins Market by Country
      • 6.1.3.2 North America Aromatase Inhibitors Market by Country
      • 6.1.3.3 North America Selective Estrogen Receptor Modulators (SERMs) Market by Country
      • 6.1.3.4 North America Dopamine Agonists Market by Country
      • 6.1.3.5 North America Others Market by Country
    • 6.1.4 North America Infertility Drugs Market by Country
      • 6.1.4.1 US Infertility Drugs Market
        • 6.1.4.1.1 US Infertility Drugs Market by End-user
        • 6.1.4.1.2 US Infertility Drugs Market by Distribution Channel
        • 6.1.4.1.3 US Infertility Drugs Market by Drug Class
      • 6.1.4.2 Canada Infertility Drugs Market
        • 6.1.4.2.1 Canada Infertility Drugs Market by End-user
        • 6.1.4.2.2 Canada Infertility Drugs Market by Distribution Channel
        • 6.1.4.2.3 Canada Infertility Drugs Market by Drug Class
      • 6.1.4.3 Mexico Infertility Drugs Market
        • 6.1.4.3.1 Mexico Infertility Drugs Market by End-user
        • 6.1.4.3.2 Mexico Infertility Drugs Market by Distribution Channel
        • 6.1.4.3.3 Mexico Infertility Drugs Market by Drug Class
      • 6.1.4.4 Rest of North America Infertility Drugs Market
        • 6.1.4.4.1 Rest of North America Infertility Drugs Market by End-user
        • 6.1.4.4.2 Rest of North America Infertility Drugs Market by Distribution Channel
        • 6.1.4.4.3 Rest of North America Infertility Drugs Market by Drug Class
  • 6.2 Europe Infertility Drugs Market
    • 6.2.1 Europe Infertility Drugs Market by End-user
      • 6.2.1.1 Europe Women Market by Country
      • 6.2.1.2 Europe Men Market by Country
    • 6.2.2 Europe Infertility Drugs Market by Distribution Channel
      • 6.2.2.1 Europe Hospital Pharmacy Market by Country
      • 6.2.2.2 Europe Specialty & Retail Pharmacy Market by Country
      • 6.2.2.3 Europe Online Pharmacy Market by Country
    • 6.2.3 Europe Infertility Drugs Market by Drug Class
      • 6.2.3.1 Europe Gonadotropins Market by Country
      • 6.2.3.2 Europe Aromatase Inhibitors Market by Country
      • 6.2.3.3 Europe Selective Estrogen Receptor Modulators (SERMs) Market by Country
      • 6.2.3.4 Europe Dopamine Agonists Market by Country
      • 6.2.3.5 Europe Others Market by Country
    • 6.2.4 Europe Infertility Drugs Market by Country
      • 6.2.4.1 Germany Infertility Drugs Market
        • 6.2.4.1.1 Germany Infertility Drugs Market by End-user
        • 6.2.4.1.2 Germany Infertility Drugs Market by Distribution Channel
        • 6.2.4.1.3 Germany Infertility Drugs Market by Drug Class
      • 6.2.4.2 UK Infertility Drugs Market
        • 6.2.4.2.1 UK Infertility Drugs Market by End-user
        • 6.2.4.2.2 UK Infertility Drugs Market by Distribution Channel
        • 6.2.4.2.3 UK Infertility Drugs Market by Drug Class
      • 6.2.4.3 France Infertility Drugs Market
        • 6.2.4.3.1 France Infertility Drugs Market by End-user
        • 6.2.4.3.2 France Infertility Drugs Market by Distribution Channel
        • 6.2.4.3.3 France Infertility Drugs Market by Drug Class
      • 6.2.4.4 Russia Infertility Drugs Market
        • 6.2.4.4.1 Russia Infertility Drugs Market by End-user
        • 6.2.4.4.2 Russia Infertility Drugs Market by Distribution Channel
        • 6.2.4.4.3 Russia Infertility Drugs Market by Drug Class
      • 6.2.4.5 Spain Infertility Drugs Market
        • 6.2.4.5.1 Spain Infertility Drugs Market by End-user
        • 6.2.4.5.2 Spain Infertility Drugs Market by Distribution Channel
        • 6.2.4.5.3 Spain Infertility Drugs Market by Drug Class
      • 6.2.4.6 Italy Infertility Drugs Market
        • 6.2.4.6.1 Italy Infertility Drugs Market by End-user
        • 6.2.4.6.2 Italy Infertility Drugs Market by Distribution Channel
        • 6.2.4.6.3 Italy Infertility Drugs Market by Drug Class
      • 6.2.4.7 Rest of Europe Infertility Drugs Market
        • 6.2.4.7.1 Rest of Europe Infertility Drugs Market by End-user
        • 6.2.4.7.2 Rest of Europe Infertility Drugs Market by Distribution Channel
        • 6.2.4.7.3 Rest of Europe Infertility Drugs Market by Drug Class
  • 6.3 Asia Pacific Infertility Drugs Market
    • 6.3.1 Asia Pacific Infertility Drugs Market by End-user
      • 6.3.1.1 Asia Pacific Women Market by Country
      • 6.3.1.2 Asia Pacific Men Market by Country
    • 6.3.2 Asia Pacific Infertility Drugs Market by Distribution Channel
      • 6.3.2.1 Asia Pacific Hospital Pharmacy Market by Country
      • 6.3.2.2 Asia Pacific Specialty & Retail Pharmacy Market by Country
      • 6.3.2.3 Asia Pacific Online Pharmacy Market by Country
    • 6.3.3 Asia Pacific Infertility Drugs Market by Drug Class
      • 6.3.3.1 Asia Pacific Gonadotropins Market by Country
      • 6.3.3.2 Asia Pacific Aromatase Inhibitors Market by Country
      • 6.3.3.3 Asia Pacific Selective Estrogen Receptor Modulators (SERMs) Market by Country
      • 6.3.3.4 Asia Pacific Dopamine Agonists Market by Country
      • 6.3.3.5 Asia Pacific Others Market by Country
    • 6.3.4 Asia Pacific Infertility Drugs Market by Country
      • 6.3.4.1 China Infertility Drugs Market
        • 6.3.4.1.1 China Infertility Drugs Market by End-user
        • 6.3.4.1.2 China Infertility Drugs Market by Distribution Channel
        • 6.3.4.1.3 China Infertility Drugs Market by Drug Class
      • 6.3.4.2 Japan Infertility Drugs Market
        • 6.3.4.2.1 Japan Infertility Drugs Market by End-user
        • 6.3.4.2.2 Japan Infertility Drugs Market by Distribution Channel
        • 6.3.4.2.3 Japan Infertility Drugs Market by Drug Class
      • 6.3.4.3 India Infertility Drugs Market
        • 6.3.4.3.1 India Infertility Drugs Market by End-user
        • 6.3.4.3.2 India Infertility Drugs Market by Distribution Channel
        • 6.3.4.3.3 India Infertility Drugs Market by Drug Class
      • 6.3.4.4 South Korea Infertility Drugs Market
        • 6.3.4.4.1 South Korea Infertility Drugs Market by End-user
        • 6.3.4.4.2 South Korea Infertility Drugs Market by Distribution Channel
        • 6.3.4.4.3 South Korea Infertility Drugs Market by Drug Class
      • 6.3.4.5 Singapore Infertility Drugs Market
        • 6.3.4.5.1 Singapore Infertility Drugs Market by End-user
        • 6.3.4.5.2 Singapore Infertility Drugs Market by Distribution Channel
        • 6.3.4.5.3 Singapore Infertility Drugs Market by Drug Class
      • 6.3.4.6 Malaysia Infertility Drugs Market
        • 6.3.4.6.1 Malaysia Infertility Drugs Market by End-user
        • 6.3.4.6.2 Malaysia Infertility Drugs Market by Distribution Channel
        • 6.3.4.6.3 Malaysia Infertility Drugs Market by Drug Class
      • 6.3.4.7 Rest of Asia Pacific Infertility Drugs Market
        • 6.3.4.7.1 Rest of Asia Pacific Infertility Drugs Market by End-user
        • 6.3.4.7.2 Rest of Asia Pacific Infertility Drugs Market by Distribution Channel
        • 6.3.4.7.3 Rest of Asia Pacific Infertility Drugs Market by Drug Class
  • 6.4 LAMEA Infertility Drugs Market
    • 6.4.1 LAMEA Infertility Drugs Market by End-user
      • 6.4.1.1 LAMEA Women Market by Country
      • 6.4.1.2 LAMEA Men Market by Country
    • 6.4.2 LAMEA Infertility Drugs Market by Distribution Channel
      • 6.4.2.1 LAMEA Hospital Pharmacy Market by Country
      • 6.4.2.2 LAMEA Specialty & Retail Pharmacy Market by Country
      • 6.4.2.3 LAMEA Online Pharmacy Market by Country
    • 6.4.3 LAMEA Infertility Drugs Market by Drug Class
      • 6.4.3.1 LAMEA Gonadotropins Market by Country
      • 6.4.3.2 LAMEA Aromatase Inhibitors Market by Country
      • 6.4.3.3 LAMEA Selective Estrogen Receptor Modulators (SERMs) Market by Country
      • 6.4.3.4 LAMEA Dopamine Agonists Market by Country
      • 6.4.3.5 LAMEA Others Market by Country
    • 6.4.4 LAMEA Infertility Drugs Market by Country
      • 6.4.4.1 Brazil Infertility Drugs Market
        • 6.4.4.1.1 Brazil Infertility Drugs Market by End-user
        • 6.4.4.1.2 Brazil Infertility Drugs Market by Distribution Channel
        • 6.4.4.1.3 Brazil Infertility Drugs Market by Drug Class
      • 6.4.4.2 Argentina Infertility Drugs Market
        • 6.4.4.2.1 Argentina Infertility Drugs Market by End-user
        • 6.4.4.2.2 Argentina Infertility Drugs Market by Distribution Channel
        • 6.4.4.2.3 Argentina Infertility Drugs Market by Drug Class
      • 6.4.4.3 UAE Infertility Drugs Market
        • 6.4.4.3.1 UAE Infertility Drugs Market by End-user
        • 6.4.4.3.2 UAE Infertility Drugs Market by Distribution Channel
        • 6.4.4.3.3 UAE Infertility Drugs Market by Drug Class
      • 6.4.4.4 Saudi Arabia Infertility Drugs Market
        • 6.4.4.4.1 Saudi Arabia Infertility Drugs Market by End-user
        • 6.4.4.4.2 Saudi Arabia Infertility Drugs Market by Distribution Channel
        • 6.4.4.4.3 Saudi Arabia Infertility Drugs Market by Drug Class
      • 6.4.4.5 South Africa Infertility Drugs Market
        • 6.4.4.5.1 South Africa Infertility Drugs Market by End-user
        • 6.4.4.5.2 South Africa Infertility Drugs Market by Distribution Channel
        • 6.4.4.5.3 South Africa Infertility Drugs Market by Drug Class
      • 6.4.4.6 Nigeria Infertility Drugs Market
        • 6.4.4.6.1 Nigeria Infertility Drugs Market by End-user
        • 6.4.4.6.2 Nigeria Infertility Drugs Market by Distribution Channel
        • 6.4.4.6.3 Nigeria Infertility Drugs Market by Drug Class
      • 6.4.4.7 Rest of LAMEA Infertility Drugs Market
        • 6.4.4.7.1 Rest of LAMEA Infertility Drugs Market by End-user
        • 6.4.4.7.2 Rest of LAMEA Infertility Drugs Market by Distribution Channel
        • 6.4.4.7.3 Rest of LAMEA Infertility Drugs Market by Drug Class

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Bayer AG
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Partnerships, Collaborations, and Agreements:
      • 7.2.5.2 Acquisition and Mergers:
  • 7.3 Novartis AG
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expense
  • 7.4 Merck & Co., Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expenses
  • 7.5 Pfizer, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional & Segmental Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Partnerships, Collaborations, and Agreements:
  • 7.6 Teva Pharmaceutical Industries Ltd.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Regional Analysis
    • 7.6.4 Research & Development Expenses
  • 7.7 Sanofi S.A.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Ferring Holdings SA
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research and Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Partnerships, Collaborations, and Agreements:
  • 7.9 Organon & Co.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Regional Analysis
    • 7.9.4 Research & Development Expenses
  • 7.10. Mankind Pharma Ltd.
    • 7.10.1 Company Overview
    • 7.10.2 Recent strategies and developments:
      • 7.10.2.1 Product Launches and Product Expansions:

LIST OF TABLES

  • TABLE 1 Global Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 2 Global Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 3 Global Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 4 Global Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 5 Global Women Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Women Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Men Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Men Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 10 Global Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 11 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Specialty & Retail Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Specialty & Retail Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 18 Global Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 19 Global Gonadotropins Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Gonadotropins Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Aromatase Inhibitors Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Aromatase Inhibitors Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Selective Estrogen Receptor Modulators (SERMs) Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Selective Estrogen Receptor Modulators (SERMs) Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Dopamine Agonists Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Dopamine Agonists Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Infertility Drugs Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Infertility Drugs Market by Region, 2022 - 2028, USD Million
  • TABLE 31 North America Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 32 North America Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 33 North America Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 34 North America Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 35 North America Women Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Women Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Men Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Men Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 40 North America Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 41 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Specialty & Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Specialty & Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 48 North America Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 49 North America Gonadotropins Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Gonadotropins Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Aromatase Inhibitors Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Aromatase Inhibitors Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Dopamine Agonists Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Dopamine Agonists Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Infertility Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 60 North America Infertility Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 61 US Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 62 US Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 63 US Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 64 US Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 65 US Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 66 US Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 67 US Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 68 US Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 69 Canada Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 70 Canada Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 71 Canada Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 72 Canada Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 73 Canada Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 74 Canada Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 75 Canada Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 76 Canada Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 77 Mexico Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 78 Mexico Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 79 Mexico Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 80 Mexico Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 81 Mexico Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 82 Mexico Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 83 Mexico Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 84 Mexico Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 89 Rest of North America Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 90 Rest of North America Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 91 Rest of North America Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 92 Rest of North America Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 93 Europe Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 94 Europe Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 95 Europe Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 96 Europe Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 97 Europe Women Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Women Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Men Market by Country, 2018 - 2021, USD Million
  • TABLE 100 Europe Men Market by Country, 2022 - 2028, USD Million
  • TABLE 101 Europe Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 102 Europe Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 103 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Specialty & Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Specialty & Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 110 Europe Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 111 Europe Gonadotropins Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Gonadotropins Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Aromatase Inhibitors Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Aromatase Inhibitors Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Europe Dopamine Agonists Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Dopamine Agonists Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 120 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 121 Europe Infertility Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Infertility Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Germany Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 124 Germany Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 125 Germany Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 126 Germany Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 127 Germany Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 128 Germany Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 129 Germany Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 130 Germany Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 131 UK Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 132 UK Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 133 UK Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 134 UK Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 135 UK Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 136 UK Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 137 UK Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 138 UK Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 139 France Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 140 France Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 141 France Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 142 France Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 143 France Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 144 France Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 145 France Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 146 France Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 147 Russia Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 148 Russia Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 149 Russia Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 150 Russia Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 151 Russia Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 152 Russia Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 153 Russia Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 154 Russia Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 155 Spain Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 156 Spain Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 157 Spain Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 158 Spain Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 159 Spain Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 Spain Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 Spain Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 162 Spain Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 163 Italy Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 164 Italy Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 165 Italy Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 166 Italy Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 167 Italy Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 168 Italy Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 169 Italy Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 170 Italy Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 173 Rest of Europe Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 174 Rest of Europe Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 175 Rest of Europe Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 176 Rest of Europe Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 177 Rest of Europe Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 178 Rest of Europe Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Women Market by Country, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Women Market by Country, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Men Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Men Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Specialty & Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Specialty & Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Gonadotropins Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Gonadotropins Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Aromatase Inhibitors Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Aromatase Inhibitors Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Dopamine Agonists Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Dopamine Agonists Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Infertility Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Infertility Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 209 China Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 210 China Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 211 China Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 212 China Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 213 China Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 214 China Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 215 China Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 216 China Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 217 Japan Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 218 Japan Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 219 Japan Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 220 Japan Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 221 Japan Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 222 Japan Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 223 Japan Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 224 Japan Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 225 India Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 226 India Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 227 India Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 228 India Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 229 India Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 230 India Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 231 India Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 232 India Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 233 South Korea Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 234 South Korea Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 235 South Korea Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 236 South Korea Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 237 South Korea Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 238 South Korea Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 239 South Korea Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 240 South Korea Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 241 Singapore Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 242 Singapore Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 243 Singapore Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 244 Singapore Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 245 Singapore Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 246 Singapore Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 247 Singapore Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 248 Singapore Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 249 Malaysia Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 250 Malaysia Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 251 Malaysia Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 252 Malaysia Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 253 Malaysia Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 254 Malaysia Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 255 Malaysia Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 256 Malaysia Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 257 Rest of Asia Pacific Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 258 Rest of Asia Pacific Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 259 Rest of Asia Pacific Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 260 Rest of Asia Pacific Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 261 Rest of Asia Pacific Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 262 Rest of Asia Pacific Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 263 Rest of Asia Pacific Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 264 Rest of Asia Pacific Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Women Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Women Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Men Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Men Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 275 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 276 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Specialty & Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Specialty & Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Gonadotropins Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Gonadotropins Market by Country, 2022 - 2028, USD Million
  • TABLE 285 LAMEA Aromatase Inhibitors Market by Country, 2018 - 2021, USD Million
  • TABLE 286 LAMEA Aromatase Inhibitors Market by Country, 2022 - 2028, USD Million
  • TABLE 287 LAMEA Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2018 - 2021, USD Million
  • TABLE 288 LAMEA Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Dopamine Agonists Market by Country, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Dopamine Agonists Market by Country, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 293 LAMEA Infertility Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 294 LAMEA Infertility Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 295 Brazil Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 296 Brazil Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 297 Brazil Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 298 Brazil Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 299 Brazil Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 300 Brazil Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 301 Brazil Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 302 Brazil Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 303 Argentina Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 304 Argentina Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 305 Argentina Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 306 Argentina Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 307 Argentina Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 308 Argentina Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 309 Argentina Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 310 Argentina Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 311 UAE Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 312 UAE Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 313 UAE Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 314 UAE Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 315 UAE Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 316 UAE Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 317 UAE Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 318 UAE Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 319 Saudi Arabia Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 320 Saudi Arabia Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 321 Saudi Arabia Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 322 Saudi Arabia Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 323 Saudi Arabia Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 324 Saudi Arabia Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 325 Saudi Arabia Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 326 Saudi Arabia Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 327 South Africa Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 328 South Africa Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 329 South Africa Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 330 South Africa Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 331 South Africa Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 332 South Africa Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 333 South Africa Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 334 South Africa Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 335 Nigeria Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 336 Nigeria Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 337 Nigeria Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 338 Nigeria Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 339 Nigeria Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 340 Nigeria Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 341 Nigeria Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 342 Nigeria Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 343 Rest of LAMEA Infertility Drugs Market, 2018 - 2021, USD Million
  • TABLE 344 Rest of LAMEA Infertility Drugs Market, 2022 - 2028, USD Million
  • TABLE 345 Rest of LAMEA Infertility Drugs Market by End-user, 2018 - 2021, USD Million
  • TABLE 346 Rest of LAMEA Infertility Drugs Market by End-user, 2022 - 2028, USD Million
  • TABLE 347 Rest of LAMEA Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 348 Rest of LAMEA Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 349 Rest of LAMEA Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 350 Rest of LAMEA Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 351 Key Information - Abbott Laboratories
  • TABLE 352 Key Information - Bayer AG
  • TABLE 353 Key Information - Novartis AG
  • TABLE 354 KEY INFORMATION - Merck & Co., Inc.
  • TABLE 355 Key Information - Pfizer, Inc.
  • TABLE 356 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 357 Key Information - Sanofi S.A.
  • TABLE 358 key information - Ferring Holdings SA
  • TABLE 359 Key Information - Organon & co.
  • TABLE 360 Key Information - Mankind Pharma Ltd.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Infertility Drugs Market share by End-user, 2021
  • FIG 3 Global Infertility Drugs Market share by End-user, 2028
  • FIG 4 Global Infertility Drugs Market by End-user, 2018 - 2028, USD Million
  • FIG 5 Global Infertility Drugs Market share by Distribution Channel, 2021
  • FIG 6 Global Infertility Drugs Market share by Distribution Channel, 2028
  • FIG 7 Global Infertility Drugs Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 8 Global Infertility Drugs Market share by Drug Class, 2021
  • FIG 9 Global Infertility Drugs Market share by Drug Class, 2028
  • FIG 10 Global Infertility Drugs Market by Drug Class, 2018 - 2028, USD Million
  • FIG 11 Global Infertility Drugs Market share by Region, 2021
  • FIG 12 Global Infertility Drugs Market share by Region, 2028
  • FIG 13 Global Infertility Drugs Market by Region, 2018 - 2028, USD Million
  • FIG 14 Swot analysis: Abbott laboratories